Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy

MLA

M. C. Kravetz, et al. “Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.” Frontiers in Pharmacology, vol. 12, May 2021. EBSCOhost, https://doi.org/10.3389/fphar.2021.648519.

APA

M. C. Kravetz, M. S. Viola, J. Prenz, M. Curi, G. F. Bramuglia, & S. Tenembaum. (2021). Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.648519

Chicago

M. C. Kravetz, M. S. Viola, J. Prenz, M. Curi, G. F. Bramuglia, and S. Tenembaum. 2021. “Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.” Frontiers in Pharmacology 12 (May). doi:10.3389/fphar.2021.648519.